Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|June 5, 2001
Immunophenotyping of leukemias using a cluster of differentiation antibody microarrayL Belov, O de la Vega, C G dos Remedios, et al.
British Journal of Haematology|May 8, 1999
Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23J R Chen, B J Gu, L P Dao, et al.
British Journal of Haematology|October 29, 1998
B-cell chronic lymphocytic leukaemia with CD8 expression: report of 10 cases and immunochemical analysis of the CD8 antigenS P Mulligan, L P Dao, S E Francis, et al.
British Journal of Haematology|July 1, 1995
The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institutionI Cunningham, S J MacCallum, M D Nicholls, et al.
Leukemia|November 7, 2008
Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparatorK E Herbert, S Morgan, H M Prince, et al.
Leukemia|October 22, 2010
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapyD A Carney, D A Westerman, C S Tam, et al.
British Journal of Cancer|June 29, 2013
Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapyC Y Cheah, M S Hofman, M Dickinson, et al.
British Journal of Cancer|July 30, 2014
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphomaC Y Cheah, K E Herbert, K O'Rourke, et al.
Leukemia|June 9, 2017
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLLJ R Brown, P Hillmen, S O'Brien, et al.
Pageof 2